Nanotechnology-Based Drug Delivery Systems: Revolutionizing Modern Therapeutics and Personalized Medicine
DOI:
https://doi.org/10.66021/pakmcr1124Abstract
Revolutionary systems for drug delivery using nanotechnology are changing how we treat disease by allowing for greater precision, effectiveness, and safety in treating patients. Nanotechnology-based drug delivery systems consist of very small materials, such as nanoparticles, liposomes, dendrimers, micelles, and nanogels (referred to as nanomaterials) that enhance the pharmacokinetics and pharmacodynamics of drugs. In addition, these systems provide targeted delivery of drugs to the area where they need to be administered; release of drugs at controlled rates over time; and for some drugs, increased bioavailability. Nanotechnology reduces the systemic toxicity associated with the delivery of drugs, therefore improving the therapeutic outcomes for the patient through their treatment of complicated diseases such as cancer, cardiovascular diseases, neurological conditions, and infectious diseases. In addition, nanotechnology's incorporation with personalized medicine has allowed for production of custom-tailored therapies based on each individual’s genetic, molecular, and physiological characteristics. Newly developed stimuli-responsive and smart nanocarriers have increased the potential for precision medicine specifically designed for real-time, site-specific drug delivery. Even with the progress that has been made in developing nanotechnology-based drug delivery systems, major challenges relating to biocompatibility, large-scale production, regulatory approval, and long-term safety still exist. This article will discuss the principles, applications, advantages, challenges, and future potential of nanotechnology-based drug delivery systems and their ability to revolutionize health care and further advance personalized medicine.
Keywords
Nanotechnology; Drug Delivery Systems; Nanoparticles; Personalized Medicine; Targeted Therapy; Controlled Drug Release; Nanocarriers; Precision Medicine; Liposomes; Therapeutics




